quinoxalines has been researched along with Neointima in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calise, D; Gadeau, AP; Gayral, S; Goudounèche, D; Hirsch, E; Kassem, S; Laffargue, M; Loirand, G; Malet, N; Martinez, LO; Pedros, C; Saoudi, A; Smirnova, NF; Vaillant, N; Wymann, MP | 1 |
1 other study(ies) available for quinoxalines and Neointima
Article | Year |
---|---|
Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.
Topics: Animals; Carotid Artery Injuries; Class Ib Phosphatidylinositol 3-Kinase; Enzyme Inhibitors; Femoral Artery; Gene Targeting; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neointima; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Rats; Rats, Sprague-Dawley; Th1 Cells; Thiazolidinediones | 2014 |